GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
Effect of Sitagliptin on Post-Prandial Glucagon and GLP-1 Levels in Patients With Type 1 Diabetes: Investigator-Initiated, Double-Blind, Randomized, Placebo-Controlled Trial - Endocrine Practice
Diabetes mellitus Typ 1: Add-on-Therapie zu Insulin im Blick
GLP-1R and Diabetes
Mini‐review: Glucagon responses in type 1 diabetes – a matter of complexity - Bisgaard Bengtsen - 2021 - Physiological Reports - Wiley Online Library
Glucagon-like Peptide-1 Plasmid Construction and Delivery for the Treatment of Type 2 Diabetes: Molecular Therapy
Welche Ursachen hat Diabetes? euroClinix® informiert
GLP-1 receptor agonists in type 1 diabetes: a MAG1C bullet? - The Lancet Diabetes & Endocrinology
Type 2 Diabetes and the Role of GLP-1 | Diabetes Education for Patients | novoMEDLINK™
GLP-1 Agonists in Type 1 Diabetes Mellitus | Semantic Scholar
Therapeutic potential of GLP-1 in type 2 diabetes mellitus | Download Table
Current Management of Glycemia in Children with Type 1 Diabetes Mellitus | NEJM
GLP-1-Rezeptoragonisten (Inkretinmimetika) | Gelbe Liste
M1Pram – ADOCIA a biotechnology company dedicated to protein delivery
Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and pre-clinical models of insulin-deficient diabetes - ScienceDirect
Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes, the ADJUNCT ONE™ treat-to-target randomised trial - Media Centre | EASD
Current and future therapies for type 1 diabetes | SpringerLink
A Specific Gut Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism - ScienceDirect
Obesity In Patients With Type 1 Diabetes - DMSO | DMSO
View of Alpha cell function in type 1 diabetes | British Journal of Diabetes
Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors | The Review of Diabetic Studies
GLP-1: Actions on Beta-cell Mass and Function
GLP-1 Agonist Effects on Glucagon Suppression
Endogenous Activation of Glucagon-Like Peptide-1 Receptor Contributes to Blood Pressure Control | Hypertension
Medikamente gegen Typ-2-Diabetes: GLP-1-Analoga | Apotheken Umschau
